Hennion & Walsh Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $321K | Buy |
+21,659
| New | +$321K | 0.01% | 792 |
|
|
2024
Q4 | – | Sell |
-36,604
| Closed | -$512K | – | 911 |
|
|
2024
Q3 | $512K | Sell |
36,604
-3,844
| -10% | -$53.8K | 0.02% | 610 |
|
|
2024
Q2 | $332K | Sell |
40,448
-342
| -0.8% | -$2.81K | 0.02% | 704 |
|
|
2024
Q1 | $314K | Buy |
40,790
+5,123
| +14% | +$39.5K | 0.02% | 678 |
|
|
2023
Q4 | $321K | Sell |
35,667
-40,206
| -53% | -$361K | 0.02% | 664 |
|
|
2023
Q3 | $678K | Sell |
75,873
-5,230
| -6% | -$46.8K | 0.04% | 446 |
|
|
2023
Q2 | $1.25M | Buy |
81,103
+1,163
| +1% | +$17.9K | 0.07% | 335 |
|
|
2023
Q1 | $1.8M | Buy |
79,940
+4,474
| +6% | +$101K | 0.11% | 227 |
|
|
2022
Q4 | $1.59M | Buy |
75,466
+31,152
| +70% | +$655K | 0.1% | 243 |
|
|
2022
Q3 | $1.09M | Sell |
44,314
-1,486
| -3% | -$36.6K | 0.07% | 299 |
|
|
2022
Q2 | $1.11M | Buy |
45,800
+4,422
| +11% | +$107K | 0.07% | 294 |
|
|
2022
Q1 | $1.07M | Buy |
41,378
+16,339
| +65% | +$421K | 0.06% | 330 |
|
|
2021
Q4 | $777K | Buy |
+25,039
| New | +$777K | 0.04% | 434 |
|